Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
about
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Deep sequencing shows that HBV ...... -positive chronic hepatitis B.
@en
type
label
Deep sequencing shows that HBV ...... -positive chronic hepatitis B.
@en
prefLabel
Deep sequencing shows that HBV ...... -positive chronic hepatitis B.
@en
P2093
P50
P1433
P1476
Deep sequencing shows that HBV ...... -positive chronic hepatitis B.
@en
P2093
Alexander Thompson
Anuj Gaggar
Danni Colledge
Darren Wong
G Mani Subramanian
Gillian Rosenberg
Harry L A Janssen
Kathleen Jackson
Kathryn M Kitrinos
P304
P356
10.1136/GUTJNL-2015-309300
P407
P577
2016-08-17T00:00:00Z